Join to View Full Profile
20 York StNew Haven, CT 06510
Phone+1 203-688-4242
Dr. Ishizuka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2015 - 2019- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2014 - 2015
- Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2013 - 2014
Harvard Medical SchoolClass of 2012
Certifications & Licensure
CT State Medical License 2020 - 2025
MA State Medical License 2016 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanoma.Tyler J Aprati, Chi-Ping Day, Daniel Lee, Alexander Pan, Justin Jee
Biorxiv. 2025-01-27 - Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era.Daniel Y Lee, Madeline McNamara, Alexander Yang, Maxim Yaskolko, Harriet Kluger
Pigment Cell & Melanoma Research. 2024-11-01 - 1 citationsImmunotherapy utilization in stage IIIA melanoma: less may be more.Alexander E Frey, Daniel M Kerekes, Sajid A Khan, Thuy T Tran, Harriet M Kluger
Frontiers in Oncology. 2024-01-01
Press Mentions
Yale Study Highlights Unmet Needs for Patients with Melanoma Who Progress or Relapse After Immunotherapy TreatmentAugust 30th, 2024
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
